It is proposed that baseline measurements be obtained prior to each period in a two-period crossover design. These measurements are used in a preliminary test for determining the validity of a test for treatment comparison and also for testing the hypothesis of equal treatment effects. The null hypothesis in this preliminary test consists of the following three hypotheses: that there is no difference in disease conditions prior to the two periods, no difference in residual effects of the drugs, and no treatment × period interaction.. A numerical example is given and the efficiencies of several methods are computed.
No takes yet. Share an insight, caveat, or question.
H. I. Patel (1983) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: